{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:32:58Z","timestamp":1764084778924,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11096-019-00866-8","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T13:33:00Z","timestamp":1561469580000},"page":"1341-1347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Initiation and continuation of antipsychotic medicines in older people following non-psychiatric hospital admission"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5063-6128","authenticated-orcid":false,"given":"Lisa M.","family":"Kalisch Ellett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole L.","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jemisha","family":"Apajee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth E.","family":"Roughead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"key":"866_CR1","volume-title":"Australian medicines handbook","author":"S Rossi","year":"2016","unstructured":"Rossi S. Australian medicines handbook. Adelaide: Australian Medicines Handbook Pty. Ltd.; 2016."},{"key":"866_CR2","unstructured":"Australian Government Department of Health. Medicines safety update. Volume 6, number 4, August 2015. Canberra: Therapeutic Goods Administration; 2015. Available from: \n                    https:\/\/www.tga.gov.au\/sites\/default\/files\/medicines-safety-update-volume-6-number-4-august-2015.pdf\n                    \n                  . 27 Sept 2016."},{"issue":"3","key":"866_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/gps.3999","volume":"29","author":"K Hatta","year":"2014","unstructured":"Hatta K, Kishi Y, Wada K, Odawara T, Takeuchi T, Shiganami T, et al. Antipsychotics for delirium in the general hospital setting in consecutive 2453 inpatients: a prospective observational study. Int J Geriatr Psychiatry. 2014;29(3):253\u201362.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"866_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S2215-0366(14)70263-9","volume":"1","author":"S Inouye","year":"2014","unstructured":"Inouye S, Marcantonio E, Metzger E. Doing damage in delirium: the hazards of antipsychotic treatment in elderly persons. Lancet Psychiatry. 2014;1(4):312\u20135.","journal-title":"Lancet Psychiatry"},{"key":"866_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/jgs.13943","volume":"64","author":"S Herzig","year":"2016","unstructured":"Herzig S, Rothberg M, Guess J, Stevens J, Marshall J, Gurwitz J, et al. Antipsychotic use in hospitalized adults: rates, indications and predictors. J Am Geriatr Soc. 2016;64:299\u2013305.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"866_CR6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/jhm.2277","volume":"9","author":"K Loh","year":"2014","unstructured":"Loh K, Ramdass S, Garb J, Brennan M, Lindenauer P, Lagu T. From hospital to community: use of antipsychotics in hospitalized elders. J Hosp Med. 2014;9(12):802\u20134.","journal-title":"J Hosp Med"},{"issue":"7","key":"866_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2165\/11588470-000000000-00000","volume":"34","author":"N Pratt","year":"2011","unstructured":"Pratt N, Roughead E, Ramsay E, Salter A, Ryan P. Risk of hospitalization for hip fracture and pneumonia associated with antipsychotic prescribing in the elderly. A self-controlled case-series analysis in an Australian health care claims database. Drug Saf. 2011;34(7):567\u201375.","journal-title":"Drug Saf"},{"key":"866_CR8","doi-asserted-by":"publisher","first-page":"a1227","DOI":"10.1136\/bmj.a1227","volume":"337","author":"I Douglas","year":"2008","unstructured":"Douglas I, Smeeth L. Exposure to antipsychotics and risk of stroke: self controlled case series study. BMJ. 2008;337:a1227.","journal-title":"BMJ"},{"key":"866_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/pds.1942","volume":"19","author":"N Pratt","year":"2010","unstructured":"Pratt N, Roughead E, Ryan P, Salter A. Antipsychotics and the risk of death in the elderly: an instrumental variable analysis using two preference based instruments. Pharmacoepidemiol Drug Saf. 2010;19:699\u2013707.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"866_CR10","unstructured":"World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical code classification index with defined daily doses. Oslo: World Health Organization Collaborating Centre for Drug Statistics Methodology; 2004. Available from: \n                    http:\/\/www.whocc.no\/atcddd\/\n                    \n                  . Cited 4 Feb 2004."},{"key":"866_CR11","unstructured":"Australian Government Department of Health and Ageing. Schedule of pharmaceutical benefits for approved pharmacists and medical practitioners. Effective 1 March 2014\u201331 March 2014: commonwealth of Australia; 2014. Available from: \n                    http:\/\/www.pbs.gov.au\/browse\/publications\n                    \n                  . Accessed 2 Sept 2016."},{"key":"866_CR12","unstructured":"National Centre for Classification in Health. The international statistical classification of diseases and related health problems, 10th revision, Australian Modification (ICD-10-AM). Sydney; 2000."},{"issue":"9","key":"866_CR13","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1445-5994.2009.02105.x","volume":"41","author":"E Roughead","year":"2011","unstructured":"Roughead E, Kalisch L, Ramsay E, Ryan P, Gilbert A. Continuity of care: when do patients visit community healthcare providers after leaving hospital? Intern Med J. 2011;41(9):662\u20137.","journal-title":"Intern Med J"},{"issue":"8","key":"866_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/pds.3459","volume":"22","author":"A Pottegard","year":"2013","unstructured":"Pottegard A, Hallas J. Assigning exposure duration to single prescriptions by use of the waiting time distribution. Pharmacoepidemiol Drug Saf. 2013;22(8):803\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"866_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"J Fine","year":"1999","unstructured":"Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"866_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/jppr.1352","volume":"48","author":"G Kassie","year":"2018","unstructured":"Kassie G, Kalisch Ellett L, Nguyen T, Roughead E. Knowledge of Australian hospital pharmacists regarding delirium in elderly patients. J Pharm Pract Res. 2018;48:116\u201323.","journal-title":"J Pharm Pract Res"},{"issue":"5","key":"866_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/0018578717750095","volume":"53","author":"G Fontaine","year":"2018","unstructured":"Fontaine G, Mortensen W, Guinto K, Scott D, Miller R. Newly initiated in-hospital antipsychotics continued atdischarge in non-psychiatric patients. Hosp Pharm. 2018;53(5):308\u201315.","journal-title":"Hosp Pharm"},{"key":"866_CR18","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jcrc.2015.08.009","volume":"30","author":"A Rowe","year":"2015","unstructured":"Rowe A, Hamilton L, Curtis R, Davis C, Smith L, Peek G, et al. Risk factors for discharge on a new antipsychotic medication after admission to an intensive care unit. J Crit Care. 2015;30:1283\u20136.","journal-title":"J Crit Care"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00866-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-019-00866-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00866-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T23:24:27Z","timestamp":1592954667000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-019-00866-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["866"],"URL":"https:\/\/doi.org\/10.1007\/s11096-019-00866-8","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"type":"print","value":"2210-7703"},{"type":"electronic","value":"2210-7711"}],"subject":[],"published":{"date-parts":[[2019,6,25]]},"assertion":[{"value":"8 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LMKE is supported by an NHMRC-ARC Dementia Research Development Fellowship (Grant identification number APP1101788). EER is supported by an NHMRC Senior Principal Research Fellowship (Grant identification number APP1110139). The sponsors had no role in the study concept or design, data acquisition or analysis, data interpretation or preparation of the manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}